Oppenheimer & Co. Inc. lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 103,199 shares of the healthcare product maker’s stock after selling 3,442 shares during the quarter. Oppenheimer & Co. Inc.’s holdings […]
Oppenheimer & Co. Inc. lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 103,199 shares of the healthcare product maker’s stock after selling 3,442 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Abbott Laboratories were worth $11,359,000 at the end […]
Cornerstone Advisory LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 13.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,439 shares of the healthcare product maker’s stock after purchasing an additional 659 shares […]
Peapack Gladstone Financial Corp boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% during the fourth quarter, HoldingsChannel.com reports. The firm owned 135,026 shares of the healthcare product maker’s stock after acquiring an additional 2,557 shares during the period. Peapack Gladstone Financial Corp’s holdings in Abbott Laboratories were worth $14,862,000 […]
Nicholas Company Inc. raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 5.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 89,350 shares of the healthcare product maker’s stock after acquiring an additional 4,560 shares during the quarter. Nicholas Company […]